Dynamic Modulation of Interactions Between Hydrophobic Tag‐Conjugated DNA Nanoprobes and Cell Membrane Facilitates ATP Imaging in the Tumor Microenvironment
Abstract
Abstract Conjugating hydrophobic tags to oligonucleotides facilitates the swift and efficient creation of membrane‐anchored DNA nanoprobes. However, the membrane‐anchoring of these hydrophobic tag‐conjugated DNA nanoprobes (HT‐DNPs) lacks specificity among different cell types. To address this challenge, we herein report a conformational switching‐based strategy for selectively anchoring HT‐DNPs to target cells. In our design, HT‐DNPs with extended or compact conformations possess weak or strong interactions with cell membrane, respectively. Thus, interactions between HT‐DNPs and cell membrane can be dynamically controlled by altering the conformation of HT‐DNPs. Initially, the extended HT‐DNPs exhibit poor membrane‐anchoring ability that is impute to their weak hydrophobic interactions with cell membrane. However, in slightly acidic conditions, HT‐DNPs intercalated with DNA i‐motif‐forming sequences can fold into a compact conformation and exhibit strong hydrophobicity, thus achieving selective and efficient anchoring of HT‐DNPs to target cells in such environments. Utilizing this method, we constructed HT‐DNPs for imaging of ATP in the tumor microenvironment (TME). Our results indicate that these HT‐DNPs can effectively accumulate at tumor sites for specific ATP imaging following intravenous injection. This strategy paves new avenues for the selective and efficient functionalization of target cells with various membrane‐anchored DNA nanostructures, including DNA nanoprobes, DNA nanocircuits, and DNA nanomachines.
Article Details
Authors (10)
Qin Li
Linlin Wang
Wanlin Xie
School of Materials Science and Engineering, Tianjin University
Qingqing Tan
Su Zhou
Haimeng Pei
Zhejiang Cancer Hospital Hangzhou Institute of Medicine (HIM) Chinese Academy of Sciences Hangzhou Zhejiang 310022 China
Hui Zhang
The Fourth Hospital of Hebei Medical University Shijiazhuang China
Jin Li
Fengli Qu
Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences
Weihong Tan
Institute of Molecular Medicine (IMM), Department of Nephrology, Molecular Cell Laboratory for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Uremia Diagnosis and Treatment Center, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, School of Medicine, School of Chemistry and Chemical Engineering